Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP330472.RAbrdhvsq3mfU-mI4ffSWPfrs3uSpfzg6XrHrPPQqiNjk130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330472.RAbrdhvsq3mfU-mI4ffSWPfrs3uSpfzg6XrHrPPQqiNjk130_provenance.
• NP173160.RAWZrNditF4xLB8LC7tVLydpV9pTlslieMuZMK2TeWLJY130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173160.RAWZrNditF4xLB8LC7tVLydpV9pTlslieMuZMK2TeWLJY130_provenance.
• NP246754.RAD5Gl19ygvsrO5FRxRA3nWpWVQORpJfe3T7uYMLUAkfQ130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246754.RAD5Gl19ygvsrO5FRxRA3nWpWVQORpJfe3T7uYMLUAkfQ130_provenance.
• assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP591067.RAnA19GiuTpLeFB6LL4xyyX6H-3pQmsEp7f4729tnreSQ130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591067.RAnA19GiuTpLeFB6LL4xyyX6H-3pQmsEp7f4729tnreSQ130_provenance.
• NP779289.RA-7tsbcw8Qx8dCWyUAioj2zx-e8RptkxVs-X2sLjRXtU130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779289.RA-7tsbcw8Qx8dCWyUAioj2zx-e8RptkxVs-X2sLjRXtU130_provenance.
• NP764662.RAWp1xEmEX_USHs_PCnx971en9hVIuqJtWWA4siPInbb0130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764662.RAWp1xEmEX_USHs_PCnx971en9hVIuqJtWWA4siPInbb0130_provenance.
• NP688966.RA4cAOaVCwUj7ThmGnnTp-M0TIZtdqieatebSIZC_8EWU130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688966.RA4cAOaVCwUj7ThmGnnTp-M0TIZtdqieatebSIZC_8EWU130_provenance.
• NP775486.RAxkjRCbcyLJ9GjdtSXWdbNTJkhEe1YbD233TSMhtHgOI130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775486.RAxkjRCbcyLJ9GjdtSXWdbNTJkhEe1YbD233TSMhtHgOI130_provenance.
• assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP248259.RAjT71pVu3ETM8lF_hMVERLqP8am9UbBrZ8sYAYRdsP2M130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248259.RAjT71pVu3ETM8lF_hMVERLqP8am9UbBrZ8sYAYRdsP2M130_provenance.
• NP248846.RAp8wxPOIqMiKTipwkNtK0uZbuBt1MMcU3prdVt2CiTIE130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248846.RAp8wxPOIqMiKTipwkNtK0uZbuBt1MMcU3prdVt2CiTIE130_provenance.
• NP268947.RAaJwH_Wz7HlBCHMYlim6ckcTlMBQYt5O55dx1iPCFMpE130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268947.RAaJwH_Wz7HlBCHMYlim6ckcTlMBQYt5O55dx1iPCFMpE130_provenance.
• NP268950.RAfq-jJVgpfCsDlH03lqef1lA7PMR1vpV27ylOZONqZ2M130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268950.RAfq-jJVgpfCsDlH03lqef1lA7PMR1vpV27ylOZONqZ2M130_provenance.
• NP268954.RAckDT_3qOE3iP3vD_p-FpGdDG81oNQx2xwiqcEiB8TO4130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268954.RAckDT_3qOE3iP3vD_p-FpGdDG81oNQx2xwiqcEiB8TO4130_provenance.
• NP268948.RArvqw3y1Mj4M4lRDo7ZuU76Z1Sx3se3Uj0924C_pHkRs130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268948.RArvqw3y1Mj4M4lRDo7ZuU76Z1Sx3se3Uj0924C_pHkRs130_provenance.
• NP248352.RAxZDK_6vvdcvxL7P47onPf8PNKyUBNv5GsP3Y1Td8c2M130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248352.RAxZDK_6vvdcvxL7P47onPf8PNKyUBNv5GsP3Y1Td8c2M130_provenance.
• NP764621.RAxO1yJYZISiBujgwDxBgh8KHgFzi6Gk4mv2pm68pwsug130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764621.RAxO1yJYZISiBujgwDxBgh8KHgFzi6Gk4mv2pm68pwsug130_provenance.
• NP268949.RAGUZaEHwmpGMepOkNJ0C5dlTYWs5Cqtq2CouJ8_MKchs130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268949.RAGUZaEHwmpGMepOkNJ0C5dlTYWs5Cqtq2CouJ8_MKchs130_provenance.
• NP268952.RAM5-bTbc21ngOeEsWHD3blOps2IszkRYpZQjIjnAm0z8130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268952.RAM5-bTbc21ngOeEsWHD3blOps2IszkRYpZQjIjnAm0z8130_provenance.
• NP268953.RAGBFTLw3H7yNzn3isbXF85Tud06IRIIShUtqcroIu_W0130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268953.RAGBFTLw3H7yNzn3isbXF85Tud06IRIIShUtqcroIu_W0130_provenance.
• NP268955.RA6OQppxDqBnFncjQyM6by2Q-C7bImnWVCUMEH6vuD-zU130_assertion description "[This study investigated whether different variants of hepatitis C virus core or E2 protein interfere with tumour necrosis factor alpha or Fas (CD95/ APO-1) antibody-induced programmed cell death in transiently transfected human hepatoma (HepG2) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268955.RA6OQppxDqBnFncjQyM6by2Q-C7bImnWVCUMEH6vuD-zU130_provenance.